rs2229562

Variant summary

Our verdict is Benign. The variant received -14 ACMG points: 0P and 14B. BP4_StrongBP6_ModerateBA1

The NM_002609.4(PDGFRB):​c.*73A>G variant causes a 3 prime UTR change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.408 in 1,407,234 control chromosomes in the GnomAD database, including 121,062 homozygotes. In-silico tool predicts a benign outcome for this variant. Variant has been reported in ClinVar as Benign (★).

Frequency

Genomes: 𝑓 0.39 ( 12297 hom., cov: 32)
Exomes 𝑓: 0.41 ( 108765 hom. )

Consequence

PDGFRB
NM_002609.4 3_prime_UTR

Scores

2

Clinical Significance

Benign criteria provided, single submitter B:1

Conservation

PhyloP100: -0.408

Publications

17 publications found
Variant links:
Genes affected
PDGFRB (HGNC:8804): (platelet derived growth factor receptor beta) The protein encoded by this gene is a cell surface tyrosine kinase receptor for members of the platelet-derived growth factor family. These growth factors are mitogens for cells of mesenchymal origin. The identity of the growth factor bound to a receptor monomer determines whether the functional receptor is a homodimer (PDGFB or PDGFD) or a heterodimer (PDGFA and PDGFB). This gene is essential for normal development of the cardiovascular system and aids in rearrangement of the actin cytoskeleton. This gene is flanked on chromosome 5 by the genes for granulocyte-macrophage colony-stimulating factor and macrophage-colony stimulating factor receptor; all three genes may be implicated in the 5-q syndrome. A translocation between chromosomes 5 and 12, that fuses this gene to that of the ETV6 gene, results in chronic myeloproliferative disorder with eosinophilia. [provided by RefSeq, Aug 2017]
PDGFRB Gene-Disease associations (from GenCC):
  • acroosteolysis-keloid-like lesions-premature aging syndrome
    Inheritance: AD Classification: DEFINITIVE, STRONG, SUPPORTIVE Submitted by: G2P, Orphanet, Labcorp Genetics (formerly Invitae)
  • myofibromatosis, infantile, 1
    Inheritance: AD Classification: DEFINITIVE, STRONG Submitted by: G2P, Labcorp Genetics (formerly Invitae)
  • skeletal overgrowth-craniofacial dysmorphism-hyperelastic skin-white matter lesions syndrome
    Inheritance: AD Classification: DEFINITIVE, STRONG, MODERATE Submitted by: Ambry Genetics, G2P, Labcorp Genetics (formerly Invitae)
  • basal ganglia calcification, idiopathic, 4
    Inheritance: AD Classification: STRONG, MODERATE Submitted by: PanelApp Australia, Ambry Genetics, Labcorp Genetics (formerly Invitae), Genomics England PanelApp
  • bilateral striopallidodentate calcinosis
    Inheritance: AD Classification: SUPPORTIVE Submitted by: Orphanet
  • infantile myofibromatosis
    Inheritance: AD Classification: SUPPORTIVE Submitted by: Orphanet
  • hereditary progressive mucinous histiocytosis
    Inheritance: AD Classification: LIMITED Submitted by: G2P

Genome browser will be placed here

ACMG classification

Classification was made for transcript

Our verdict: Benign. The variant received -14 ACMG points.

BP4
Computational evidence support a benign effect (BayesDel_noAF=-0.67).
BP6
Variant 5-150115690-T-C is Benign according to our data. Variant chr5-150115690-T-C is described in ClinVar as Benign. ClinVar VariationId is 1221159.Status of the report is criteria_provided_single_submitter, 1 stars.
BA1
GnomAd4 highest subpopulation (NFE) allele frequency at 95% confidence interval = 0.429 is higher than 0.05.

Transcripts

RefSeq

Gene Transcript HGVSc HGVSp Effect Exon rank MANE Protein UniProt
PDGFRBNM_002609.4 linkc.*73A>G 3_prime_UTR_variant Exon 23 of 23 ENST00000261799.9 NP_002600.1 P09619-1Q59F04
PDGFRBNM_001355016.2 linkc.*73A>G 3_prime_UTR_variant Exon 22 of 22 NP_001341945.1
PDGFRBNM_001355017.2 linkc.*73A>G 3_prime_UTR_variant Exon 23 of 23 NP_001341946.1

Ensembl

Gene Transcript HGVSc HGVSp Effect Exon rank TSL MANE Protein Appris UniProt
PDGFRBENST00000261799.9 linkc.*73A>G 3_prime_UTR_variant Exon 23 of 23 1 NM_002609.4 ENSP00000261799.4 P09619-1
PDGFRBENST00000520579.5 linkn.*2708A>G downstream_gene_variant 1 ENSP00000430026.1 E5RH16

Frequencies

GnomAD3 genomes
AF:
0.394
AC:
59905
AN:
151914
Hom.:
12274
Cov.:
32
show subpopulations
Gnomad AFR
AF:
0.423
Gnomad AMI
AF:
0.383
Gnomad AMR
AF:
0.354
Gnomad ASJ
AF:
0.463
Gnomad EAS
AF:
0.111
Gnomad SAS
AF:
0.325
Gnomad FIN
AF:
0.234
Gnomad MID
AF:
0.462
Gnomad NFE
AF:
0.434
Gnomad OTH
AF:
0.407
GnomAD4 exome
AF:
0.410
AC:
514094
AN:
1255202
Hom.:
108765
Cov.:
18
AF XY:
0.407
AC XY:
250524
AN XY:
615562
show subpopulations
African (AFR)
AF:
0.415
AC:
11329
AN:
27296
American (AMR)
AF:
0.259
AC:
6715
AN:
25898
Ashkenazi Jewish (ASJ)
AF:
0.456
AC:
8538
AN:
18716
East Asian (EAS)
AF:
0.109
AC:
3980
AN:
36428
South Asian (SAS)
AF:
0.320
AC:
20261
AN:
63326
European-Finnish (FIN)
AF:
0.248
AC:
10005
AN:
40274
Middle Eastern (MID)
AF:
0.451
AC:
1585
AN:
3512
European-Non Finnish (NFE)
AF:
0.436
AC:
430686
AN:
987544
Other (OTH)
AF:
0.402
AC:
20995
AN:
52208
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.497
Heterozygous variant carriers
0
13988
27976
41964
55952
69940
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Exome Het
Exome Hom
Variant carriers
0
13294
26588
39882
53176
66470
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
GnomAD4 genome
AF:
0.394
AC:
59971
AN:
152032
Hom.:
12297
Cov.:
32
AF XY:
0.382
AC XY:
28400
AN XY:
74326
show subpopulations
African (AFR)
AF:
0.423
AC:
17527
AN:
41442
American (AMR)
AF:
0.354
AC:
5406
AN:
15286
Ashkenazi Jewish (ASJ)
AF:
0.463
AC:
1604
AN:
3468
East Asian (EAS)
AF:
0.110
AC:
569
AN:
5154
South Asian (SAS)
AF:
0.326
AC:
1569
AN:
4814
European-Finnish (FIN)
AF:
0.234
AC:
2485
AN:
10604
Middle Eastern (MID)
AF:
0.476
AC:
140
AN:
294
European-Non Finnish (NFE)
AF:
0.434
AC:
29467
AN:
67952
Other (OTH)
AF:
0.406
AC:
856
AN:
2110
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.506
Heterozygous variant carriers
0
1895
3790
5686
7581
9476
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Genome Het
Genome Hom
Variant carriers
0
570
1140
1710
2280
2850
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
Alfa
AF:
0.417
Hom.:
9056
Bravo
AF:
0.400
Asia WGS
AF:
0.222
AC:
773
AN:
3478

ClinVar

Significance: Benign
Submissions summary: Benign:1
Revision: criteria provided, single submitter
LINK: link

Submissions by phenotype

not provided Benign:1
Jan 10, 2019
GeneDx
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

- -

Computational scores

Source: dbNSFP v4.3

Name
Calibrated prediction
Score
Prediction
BayesDel_noAF
Benign
-0.67
CADD
Benign
5.7
DANN
Benign
0.84
PhyloP100
-0.41
Mutation Taster
=100/0
polymorphism (auto)

Splicing

Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
0.0
Details are displayed if max score is > 0.2

Find out detailed SpliceAI scores and Pangolin per-transcript scores at spliceailookup.broadinstitute.org

Publications

Other links and lift over

dbSNP: rs2229562; hg19: chr5-149495253; COSMIC: COSV53833139; COSMIC: COSV53833139; API